Skip to content

Effectiveness of AI and mHealth-based intervention for prevention and control of type 2 diabetes in primary healthcare

Effectiveness of AI and mHealth-based intervention for prevention and control of type 2 diabetes in primary healthcare

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300068952
Enrollment
Unknown
Registered
2023-03-02
Start date
2023-03-10
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes

Interventions

Intervention group for T2DM patients:T2DM self-management behavior intervention program based on AI and mHealth
Control group for T2DM patients:Basic public health services for patients with T2DM
Intervention group for T2DM high-risk patients:T2DM self-management behavior intervention program based on AI and mHealth
Control group for T2DM high-risk patients:Basic public health services for people

Sponsors

Peking University School of Public Health
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Diagnostic criteria for type 2 diabetes mellitus: fasting blood glucose >=7.0mmol/L or OGTT2 hour blood glucose >=11.1mmol/L or HbA1C>=6.5%; 2. Identification of high-risk groups of diabetes: According to the National Guidelines for Prevention and Management of Grassroots Diabetes (2018), 12 risk factors can be considered when defining high-risk groups of type 2 diabetes. Based on the accessibility of physical examination and screening data, this study selected several major risk factors for screening high-risk groups: (1) Aged >=40 years; (2) A history of prediabetes (IGT, IFG, or both); (3) Overweight (BMI>=24 kg/m^2) or obese (BMI>=28 kg/m^2) and/or central obesity (waist circumference >=90 cm for men and >=85 cm for women); (4) Sedentary lifestyle; (5) Family history of type 2 diabetes in first-degree relatives; (6) Women with a history of gestational diabetes; (7) Hypertension (systolic blood pressure >=140 mmHg and/or diastolic blood pressure >=90 mmHg), or being treated for blood pressure reduction; (8) Abnormal blood fat (HDL-C=2.22mmol/L), or receiving lipid regulation therapy; 3. Aged 18-75 years (note: diabetes risk group >=40 years old); 4. Permanent residents of Beijing (annual travel time less than 1 month); 5. Did not take any psychotropic drugs before enrollment; 6. Able to use smart phones and familiar with wechat functions; 7. Volunteer to participate in the study and fill in the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Complicated with severe heart, brain, kidney, eye, foot and nervous system complications (proliferative retinopathy, nephropathy stage IV or above or creatinine >2mg/dl, cardiac function grade III or below, cerebrovascular accident sequelae, diabetic foot grade I or above); 2. Patients with mobility difficulties, confusion and abnormal spirit; 3. Patients suffering from tumor and receiving radiotherapy or chemotherapy within half a year; 4. Participating in other similar research projects; 5. Uncooperative.

Design outcomes

Primary

MeasureTime frame
fasting blood glucose;glycosylated hemoglobin;T2DM self-management skills;

Secondary

MeasureTime frame
body mass index, BMI;waistine;blood pressure;blood lipid;

Countries

China

Contacts

Public ContactSun Xinying

Department of Social Medicine and Health Education, School of Public Health, Peking University

xysun@bjmu.edu.cn+86 136 9121 2050

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026